Unlocking Asian Cell & Gene Innovation
Connecting Asia's advanced therapies ecosystem with global life science leaders
Partnerships • R&D • Investment • Technology • Regulatory
Final Days for Early Bird Savings!
Register now to secure your ticket at a discounted rate and accelerate cell and gene therapy innovation.
Early bird pricing ends Friday, December 12.
A Decade of Expertise, Now in China: Cell & Gene Therapy Summit 2026
With over a decade of experience hosting premier cell and gene therapy events in the US and Europe, attracting 1,500+ attendees annually, Cell & Gene Therapy International is bringing its expertise to China. The 2026 summit in Shanghai is designed to foster collaboration among top researchers, biopharmaceutical leaders, and industry pioneers, with a focus on cutting-edge R&D, manufacturing excellence, and strategic partnerships. Attendees will gain unparalleled insights into breakthrough methodologies across cell therapies, gene editing platforms, viral vector technologies, and the discovery-to-clinic continuum—empowering them to drive innovation and growth in the China market.
What to Expect at Cell & Gene Therapy Summit 2026
+
Global leaders at the co-located ChinaBio Partnering Forum and Antibody & ADC Summit
+
Leading cell and gene therapy experts
+
Hours of networking with industry professionals
Top Cell and Gene Therapy Companies Attending in 2026
Your Roadmap to Advanced Therapies and Next-Gen Solutions: Agenda is Live
Step into the future of cell & gene therapies at the Cell & Gene Therapy Summit at ChinaBio®
Experience transformative discussions, groundbreaking research, and insights from visionary leaders. Explore how Asia’s advanced therapies ecosystem is reshaping partnerships, R&D, investment, technology, and regulatory frameworks to define the next era of cell and gene therapy.
Global Pioneers in Cell and Gene Therapy: Driving Innovation, Manufacturing Excellence and Strategic Investment
Mapping the Road from Cutting-Edge Discoveries to Commercial Success
Explore the key themes shaping Cell & Gene Therapies Summit 2026, designed to help you navigate the entire lifecycle of CGT development
R&D Innovations - New Modalities, Solid Tumours and Larger Patient Populations
Manufacturing Efficiency and Cost Reduction Strategies for Autologous, Allogeneic and AAV Therapies
In Vivo Cell Therapy Development & Clinical Advances
Novel Technology Innovations and Platforms
Automation & Closed Systems
Navigate the Global Regulatory Landscape
Beyond the Session Room
It’s not just about the talks. From coffee breaks to networking receptions, every moment is designed to spark connections, collaborations, and new business opportunities.
Exhibit Hall
Step into the showcase of innovation. Explore the latest tools, platforms, and solutions in manufacturing, analytics, and clinical development with a spotlight on technologies shaping China’s biotech market.
Panel Discussions: Your Questions, Answered
Curious about navigating China’s funding landscape or unlocking partnerships with big pharma? Our keynote panels bring investors and industry leaders together to tackle the questions that matter most.
partneringONE™: Strategic Networking Made Simple
Plan smarter, connect faster. partneringONE™ helps you identify the right people, schedule targeted 1:1 meetings, and turn introductions into lasting collaborations.
Co-Located with ChinaBio® Partnering Forum and Antibody & ADC Innovation Summit
Your Cell and Gene Therapy Summit registration unlocks full access to two additional powerhouse events. Together, they draw 1,000+ scientists, executives, and investors - creating a unique ecosystem where science, strategy, and partnerships thrive in the heart of China’s biotech boom.
China: The Rising Powerhouse of Cell & Gene Therapy Innovation
Optimise your go-to-market strategies by connecting face-to-face with China's leading biopharma executives, regulatory authorities, and research pioneers shaping the future of cell and gene therapy
Unparalleled Market Growth
Home to 1,000+ cell and gene therapy developers across Asia-Pacific, with China's CGT market projected to reach $4 billion by 2027, establishing the region as a global industry powerhouse.
Robust Clinical Development
With over 1,000 active cell and gene therapy clinical trials in China alone, offering unprecedented access to innovation pipelines and research partnerships.
Breakthrough Regulatory Milestones
China's landmark 2025 approvals—including its first mesenchymal stem cell therapy and first gene editing product to receive FDA RMAT designation—showcase the country's accelerating regulatory framework.
Engage a qualified audience of global cell and gene therapy executives and scientists!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.
Contact Roshni Shah to learn more about sponsorship opportunities: RShah@informaconnectls.com
